Several predictive response factors to TACE have been described, such as baseline tumor burden, tumor biology in terms of tolerance to ischemic stress and sensitivity to chemotherapeutic agents, alpha-feto protein(AFP), and liver function factors (e.g., albumin and bilirubin) as well as procedure-related factors [48,49]. The gene discussed is AFP; the disease is neoplasm.